Vaishali Pharma Ltd

Vaishali Pharma Ltd

₹ 169 9.25%
04 Jul 3:59 p.m.
About

Incorporated in 1989, Vaishali Pharma Ltd
does marketing of pharmaceutical products including active pharmaceutical ingredients[1]

Key Points

Business Overview:[1]
VPL is certified by ISO 9001:2008 and provides 1500+ products and 250+ Brands including APIs, Formulations, Surgical, Herbals, Veterinary, Nutraceutical, Oncology, and other healthcare products in 35+ locations

  • Market Cap 181 Cr.
  • Current Price 169
  • High / Low 204 / 115
  • Stock P/E 251
  • Book Value 40.0
  • Dividend Yield 0.00 %
  • ROCE 4.77 %
  • ROE 1.73 %
  • Face Value 10.0

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -1.75%
  • Promoter holding is low: 24.9%
  • Company has a low return on equity of 11.4% over last 3 years.
  • Earnings include an other income of Rs.2.03 Cr.
  • Company has high debtors of 209 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
18.88 8.27 19.86 22.28 25.41 10.18 13.16 20.09 26.24 13.42 12.57 27.90 32.40
20.23 7.01 17.64 19.79 24.53 7.98 10.57 16.53 25.46 11.11 9.92 24.95 39.19
Operating Profit -1.35 1.26 2.22 2.49 0.88 2.20 2.59 3.56 0.78 2.31 2.65 2.95 -6.79
OPM % -7.15% 15.24% 11.18% 11.18% 3.46% 21.61% 19.68% 17.72% 2.97% 17.21% 21.08% 10.57% -20.96%
0.57 0.57 0.36 0.31 0.55 0.43 0.74 0.53 0.53 0.36 0.30 0.47 0.91
Interest 1.07 0.65 0.61 0.55 0.65 0.53 0.53 0.42 0.54 0.43 0.47 0.43 0.40
Depreciation 0.11 0.10 0.10 0.10 0.15 0.09 0.14 0.12 0.15 0.12 0.12 0.12 0.14
Profit before tax -1.96 1.08 1.87 2.15 0.63 2.01 2.66 3.55 0.62 2.12 2.36 2.87 -6.42
Tax % 26.53% 25.00% 25.13% 25.12% 68.25% 24.88% 24.81% 25.07% 29.03% 25.00% 27.97% 26.13% 26.95%
-1.45 0.81 1.40 1.61 0.20 1.51 1.99 2.66 0.44 1.59 1.70 2.11 -4.68
EPS in Rs -1.37 0.77 1.33 1.53 0.19 1.43 1.89 2.52 0.42 1.50 1.60 1.99 -4.37
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
118.81 120.71 94.56 66.71 63.97 67.76 75.09 60.09 53.77 75.82 69.66 86.28
117.24 118.23 94.85 66.16 60.49 64.97 73.01 59.18 51.12 68.94 60.28 85.14
Operating Profit 1.57 2.48 -0.29 0.55 3.48 2.79 2.08 0.91 2.65 6.88 9.38 1.14
OPM % 1.32% 2.05% -0.31% 0.82% 5.44% 4.12% 2.77% 1.51% 4.93% 9.07% 13.47% 1.32%
0.29 0.86 4.26 3.18 0.93 1.66 1.98 2.17 1.81 1.79 2.23 2.03
Interest 0.94 2.68 3.37 3.37 3.10 2.85 2.66 2.56 2.63 2.49 2.26 1.74
Depreciation 0.03 0.04 0.45 0.37 0.28 0.25 0.27 0.44 0.43 0.46 0.50 0.51
Profit before tax 0.89 0.62 0.15 -0.01 1.03 1.35 1.13 0.08 1.40 5.72 8.85 0.92
Tax % 32.58% 50.00% -6.67% -300.00% 32.04% 40.74% 37.17% 62.50% 25.71% 29.72% 25.31% 22.83%
0.60 0.30 0.16 -0.03 0.71 0.80 0.71 0.03 1.05 4.02 6.60 0.72
EPS in Rs 7.50 3.75 2.00 -0.38 1.48 0.76 0.68 0.03 1.00 3.81 6.26 0.67
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -3%
5 Years: 3%
3 Years: 17%
TTM: 24%
Compounded Profit Growth
10 Years: 9%
5 Years: 0%
3 Years: -12%
TTM: -89%
Stock Price CAGR
10 Years: %
5 Years: 49%
3 Years: 58%
1 Year: 36%
Return on Equity
10 Years: 8%
5 Years: 9%
3 Years: 11%
Last Year: 2%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 0.50 0.50 0.50 0.50 3.00 6.59 6.59 10.55 10.55 10.55 10.55 10.72
Reserves 2.27 2.57 2.74 2.70 0.97 14.01 14.81 10.84 11.87 15.81 29.99 32.12
9.60 18.77 25.09 21.04 22.86 18.40 17.07 17.04 17.85 20.81 14.73 13.49
36.21 31.59 17.47 25.17 18.04 25.22 30.28 27.77 45.85 34.45 23.63 23.63
Total Liabilities 48.58 53.43 45.80 49.41 44.87 64.22 68.75 66.20 86.12 81.62 78.90 79.96
0.18 0.25 1.68 1.40 1.29 1.26 1.34 1.49 1.22 1.18 1.98 2.26
CWIP 0.00 0.36 0.00 0.00 0.00 0.08 0.04 0.08 0.05 0.49 0.67 0.00
Investments 0.00 0.17 0.38 0.38 0.38 0.43 0.43 0.43 0.43 0.43 0.43 0.43
48.40 52.65 43.74 47.63 43.20 62.45 66.94 64.20 84.42 79.52 75.82 77.27
Total Assets 48.58 53.43 45.80 49.41 44.87 64.22 68.75 66.20 86.12 81.62 78.90 79.96

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
3.80 -7.04 -3.72 4.59 0.46 -9.46 4.31 3.22 2.01 1.32 1.08 0.81
0.14 -0.24 1.78 3.07 0.69 1.06 -0.28 -0.02 -0.11 -0.85 0.28 1.20
-3.60 6.49 1.93 -7.62 -1.20 8.50 -3.99 -3.14 -1.81 0.42 -1.73 -1.42
Net Cash Flow 0.33 -0.79 0.00 0.04 -0.05 0.10 0.04 0.06 0.09 0.89 -0.37 0.59

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 115.64 115.51 132.63 221.16 213.80 240.14 240.22 285.67 452.97 281.67 280.90 209.11
Inventory Days 17.17 26.04 13.28 19.77 7.48 11.39 5.21 6.29 4.67 3.62 20.36 1.86
Days Payable 115.33 98.99 65.64 144.63 99.98 136.37 130.38 168.82 320.63 163.13 120.15 95.10
Cash Conversion Cycle 17.47 42.56 80.27 96.29 121.29 115.16 115.05 123.14 137.01 122.16 181.11 115.87
Working Capital Days 29.74 58.54 97.81 109.10 114.97 177.17 153.70 195.77 238.60 196.41 252.82 209.49
ROCE % 13.64% 19.29% 14.03% 12.78% 16.17% 12.76% 9.78% 6.87% 10.24% 18.78% 21.69%

Shareholding Pattern

Numbers in percentages

10 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024May 2024
56.31% 56.31% 26.74% 26.74% 26.74% 26.74% 26.74% 26.74% 26.62% 26.62% 26.32% 24.87%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.57% 0.00% 0.00% 0.00% 0.00% 0.02%
43.69% 43.69% 73.25% 73.26% 73.26% 73.24% 72.69% 73.26% 73.38% 73.38% 73.68% 75.11%
No. of Shareholders 10,82210,2119,6119,3908,3478,9549,3769,5739,9839,1819,39010,297

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents